News NHS should fund GSK's £526,000 "bubble baby" drug - NICE Strimvelis is most expensive drug cleared by NICE
Views & Analysis Patient involvement in HTA Considering the essential role of patient experience in HTA and the role of pharma.
News NICE to reassess Pfizer blood cancer drug Company successfully appealed against rejection last summer
Views & Analysis What is pharmaceutical market access? Findings from a comprehensive survey on the topic of market access.
Views & Analysis UK life sciences: the impact of a cycle of affordability and... The changing landscape for drug pricing and some pointers for the UK life sciences sector.
News NHS funding for five MS drugs under threat NICE calls for further discounts on beta-interferons and Copaxone
News GBL joins CVC in €10.7bn takeover bid for Recordati A consortium of investors has made a €10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
